Navigation Links
SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years
Date:12/8/2011

kelihood to progress to type 2 diabetes compared to subjects receiving top-dose Qnexa and a two times greater likelihood than patients on mid-dose Qnexa.

 

Qnexa therapy was well tolerated, with no new adverse events observed in the second year of study. The most common side effects were upper respiratory infection, constipation, tingling, sinus infection, dry mouth and runny nose. There were no drug-related serious adverse events reported. The completion rate in SEQUEL was approximately 83% for both Qnexa doses and 86% for the placebo group. Discontinuations due to adverse events were 4.5% and 4.4% for the mid- and top-dose, respectively, and 3.1% for the placebo group.

About the SEQUEL Study

SEQUEL (OB-305) was a double-blind, placebo-controlled, three-arm, extension study. Patients continued receiving the same treatment assignment to which they had been randomized in the 56-week CONQUER study in a blinded fashion: either once-daily treatment with top-dose Qnexa (n=295), mid-dose Qnexa (n=153), or placebo (n=227). The SEQUEL study was a 52-week extension study for a subset of patients who completed the CONQUER study. The total study period was 108 weeks. SEQUEL included 676 obese or overweight patients, all of whom had two or more weight-related co-morbidities and an average baseline BMI of 36.1. Throughout the 108-week treatment period, all patients were advised to follow a modest lifestyle modification program including reduction of food intake by 500 calories per day.  The SEQUEL study was conducted at 36 sites in the United States.

Approximately 20% of SEQUEL subjects had type 2 diabetes at baseline and had been treated with lifestyle modifications alone or single-agent metformin. In this subgroup, weight loss associated with Qnexa had a favorable impact on glycemic control without a need for added oral hypoglycemic agents. In subjects without type 2 diabetes at baseline, the favo
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Additional Analysis from Two-Year Sequel Study of QNEXA Featured at The 2011 Annual Scientific Meeting of The Obesity Society
2. Data From QNEXA Sequel Study Featured at the 47th EASD Annual Meeting
3. SequelMed EMR Version 8 Certified by Ohio Board of Pharmacy
4. Sequel Systems, Inc. Meaningful Use EHR Receives ONC-ATCB 2011/2012 Certification
5. Sequella and University of Maryland Restate Exclusive License for Jointly Owned Event Marker System Technology
6. Sequella Receives American Recovery and Reinvestment Funding Through the NIH
7. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
8. Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
9. TIs new MSP430™ microcontrollers enable more performance and higher precision in home automation, industrial and portable medical applications
10. GiiResearch.com: Computed Tomography (CT) Systems - Technological Advances and Positive Clinical Trial Evidences to Drive the Market
11. GiiResearch.com: Insulin Pumps - Availability of Reimbursement and Favorable Clinical Trial Data to Drive Market Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... --  Wellcentive , the industry leader in end-to-end ... today being named one of the four finalists ...  Sponsored by Intel, the world leader in computing ... companies developing leading-edge technology and unique approaches to ... Wellcentive,s Mason Beard , senior vice ...
(Date:11/21/2014)... , Nov. 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... priced its offering of $80,000,000 aggregate principal amount of ... in a private offering within the United ... qualified institutional buyers pursuant to Rule 144A under the ... Lexicon has also granted the initial purchasers an option ...
(Date:11/18/2014)... 2014 Respiratory Motion and IMI Co announced ... and services providers in Japan , ... innovative respiratory depression monitor, the ExSpiron™. As part of ... together to connect the clinical community in promoting patient ... bringing innovative medical devices and new technology to the ...
Breaking Medicine Technology:Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3Lexicon Announces Pricing Of Convertible Senior Notes Offering 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4
... Sept. 23, 2011 A pharmaceutical company,s marketing strategy ... introducing a new brand in a space where the ... two-thirds of companies, the most frequent changes require shifting ... activities, such as professional relations, promotional literature, sampling, and ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... Company intends to release its third quarter 2011 financial results ... the U.S. financial markets.  The Company will also host a ... November 1, 2011 to discuss its financial results and provide ...
Cached Medicine Technology:Pharmaceutical Marketing Strategy Balances Support Between New & Established Products in the Same Indication 2Watson to Host Conference Call and Webcast to Discuss Third Quarter 2011 Earnings 2
(Date:11/21/2014)... Nov. 20, 2014 (HealthDay News) -- The cost of ... percent in recent years, climbing to more than $322 ... increases in cost were seen with prediabetes care, which ... jumped 82 percent, the researchers added. In 2012, ... totaled more than $1,000 for every American. That total ...
(Date:11/21/2014)... 21, 2014 MLF Biotech, Inc. has ... . Liv-Pro® Probiotics for Pets helps maintain digestive health ... a pet's intestinal flora after it experiences a period ... Liv-Pro Probiotics for Pets is a proprietary blend of ... seven live active bacteria strains that are safe and ...
(Date:11/21/2014)... CA (PRWEB) November 21, 2014 Big ... in an upcoming episode of Innovations with Ed Begley ... and show times TBA. , Big Bud Farms, growers ... for growing, harvesting, and utilization of medical marijuana. , ... Big Bud Farms’ wide variety of products for medicating. ...
(Date:11/21/2014)... 21, 2014 Midway through the research ... Inc.’s (AIS) annual Directory of Health Plans, preliminary data ... Directory of Health Plans is a comprehensive resource with ... in the U.S. The 2015 edition will ... AIS’s Directory and Databases Division, the company’s exclusive in-house ...
(Date:11/21/2014)... DressVe.com , a renowned women’s dress wholesaler and retailer ... fashion accessories. Furthermore, the company has launched its Special Black ... all its fashion items. Also, orders above $59 are qualified ... company, their wedding dresses and prom dresses are very popular ... rates. , The CEO says “We are glad to ...
Breaking Medicine News(10 mins):Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2Health News:DressVe.com Announces Its 2014 Special Friday Sales 2
... risk of tooth decay as it damages the tooth enamel due ... risk of tooth decay which cannot be repaired if affected//. The ... fizzy drinks can be reduced. ,Using a straw can ... positioned to the inside of the mouth which reduces the contact ...
... Public Health says that low income groups and those with ... diseases//. The study arrived at these conclusions after analyzing data ... Maryland. ,The researchers say that a person's income ... bleeding gums and that a person with low income was ...
... care system, after widespread devastation by the Tsunami that stuck ... individuals lost their lives and a million others were injured ... great help in the process of rejuvenation of the health ... part of the health care system in Indonesia. Infact 80 ...
... In a new study that is to appear in ... Hopkins researcher suggests that cancers might begin with epigenetic ... occur in individuals whose genes have been altered by ... changes occur in the development of cancers, but there ...
... identified two genes essential for the development of muscles.Da-Zhi Wang ... Chapel Hill // said that the genes are among a ... years ago. ,Only in the past few years ... multi-cellular organisms, including humans, the study authors said in an ...
... of using private hospital costs as a ruse to put ... // . ,Private health insurers are believed to have ... approve an annual premium increase of between 5 per cent ... be their fifth successive rise at double the inflation rate. ...
Cached Medicine News:Health News:Indonesian Health Care System Rebuilt After Tsunami 2Health News:Cancer Begins With Epigenetic Changes: Study 2Health News:Australian Health funds stand accused 2
Penfield Watchmaker Forceps. Tip width 0.9 mm....
Vertigraft femoral shaft an large femoral cross-section designed primarily for use in lumbar corpectomy procedures. Freeze dried preservation....
... Ocelot stackable cage system provides anterior column ... total vertebrectomies from T1 to L5. The ... Carbon fiber polymer cages that are stacked ... needs. The Peek Carbon fiber reinforced polymer ...
... bone graft substitute (beta-tricalcium ... Chronos is an advantageous ... It shortens operative time, ... quantity and quality of ...
Medicine Products: